Hunt A, Rasor B, Seki K, Ekas H, Warfel K, Karim A
Chem Rev. 2024; 125(1):91-149.
PMID: 39700225
PMC: 11719329.
DOI: 10.1021/acs.chemrev.4c00116.
Sieber A, Parr M, von Ehr J, Dhamotharan K, Kielkowski P, Brewer T
Nat Commun. 2024; 15(1):10465.
PMID: 39622818
PMC: 11611912.
DOI: 10.1038/s41467-024-54556-9.
Katoh T, Suga H
Nat Rev Chem. 2024; 8(12):879-892.
PMID: 39433956
DOI: 10.1038/s41570-024-00656-5.
Mudryi V, Frister J, Peng B, Wohlgemuth I, Peske F, Rodnina M
Nucleic Acids Res. 2024; 52(19):11870-11883.
PMID: 39315709
PMC: 11514478.
DOI: 10.1093/nar/gkae815.
Brischigliaro M, Kruger A, Moran J, Antonicka H, Ahn A, Shoubridge E
Nucleic Acids Res. 2024; 52(16):9710-9726.
PMID: 39036954
PMC: 11381339.
DOI: 10.1093/nar/gkae645.
Tuning tRNAs for improved translation.
Weiss J, Decker J, Bolano A, Krahn N
Front Genet. 2024; 15:1436860.
PMID: 38983271
PMC: 11231383.
DOI: 10.3389/fgene.2024.1436860.
Resolution of ribosomal stalling by EF-P and ABCF ATPases YfmR and YkpA/YbiT.
Takada H, Fujiwara K, Atkinson G, Chiba S, Hauryliuk V
Nucleic Acids Res. 2024; 52(16):9854-9866.
PMID: 38943426
PMC: 11381351.
DOI: 10.1093/nar/gkae556.
In Vitro Selection of Macrocyclic l-α/d-α/β/γ-Hybrid Peptides Targeting IFN-γ/IFNGR1 Protein-Protein Interaction.
Miura T, Lee K, Katoh T, Suga H
J Am Chem Soc. 2024; 146(26):17691-17699.
PMID: 38888290
PMC: 11229689.
DOI: 10.1021/jacs.4c01979.
Cyclic β-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease.
Miura T, Malla T, Brewitz L, Tumber A, Salah E, Lee K
Bull Chem Soc Jpn. 2024; 97(5):uoae018.
PMID: 38828441
PMC: 11141402.
DOI: 10.1093/bulcsj/uoae018.
Engineering tRNAs for the Ribosomal Translation of Non-proteinogenic Monomers.
Sigal M, Matsumoto S, Beattie A, Katoh T, Suga H
Chem Rev. 2024; 124(10):6444-6500.
PMID: 38688034
PMC: 11122139.
DOI: 10.1021/acs.chemrev.3c00894.
Fine-tuning the tRNA anticodon arm for multiple/consecutive incorporations of β-amino acids and analogs.
Katoh T, Suga H
Nucleic Acids Res. 2024; 52(11):6586-6595.
PMID: 38572748
PMC: 11194099.
DOI: 10.1093/nar/gkae219.
YfmR is a translation factor that prevents ribosome stalling and cell death in the absence of EF-P.
Hong H, Prince C, Tetreault D, Wu L, Feaga H
Proc Natl Acad Sci U S A. 2024; 121(8):e2314437121.
PMID: 38349882
PMC: 10895253.
DOI: 10.1073/pnas.2314437121.
Elongation Factor P Modulates the Incorporation of Structurally Diverse Noncanonical Amino Acids into Dihydrofolate Reductase.
Daskalova S, Dedkova L, Maini R, Talukder P, Bai X, Roy Chowdhury S
J Am Chem Soc. 2023; 145(43):23600-23608.
PMID: 37871253
PMC: 10762953.
DOI: 10.1021/jacs.3c07524.
YfmR is a translation factor that prevents ribosome stalling and cell death in the absence of EF-P.
Hong H, Prince C, Tetreault D, Wu L, Feaga H
bioRxiv. 2023; .
PMID: 37577462
PMC: 10418254.
DOI: 10.1101/2023.08.04.552005.
Translation initiation with exotic amino acids using EF-P-responsive artificial initiator tRNA.
Katoh T, Suga H
Nucleic Acids Res. 2023; 51(15):8169-8180.
PMID: 37334856
PMC: 10450175.
DOI: 10.1093/nar/gkad496.
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ-amino acids targeting the SARS-CoV-2 main protease.
Miura T, Malla T, Owen C, Tumber A, Brewitz L, McDonough M
Nat Chem. 2023; 15(7):998-1005.
PMID: 37217786
PMC: 10322702.
DOI: 10.1038/s41557-023-01205-1.
Translation factor accelerating peptide bond formation on the ribosome: EF-P and eIF5A as entropic catalysts and a potential drug targets.
Mudryi V, Peske F, Rodnina M
BBA Adv. 2023; 3:100074.
PMID: 37082265
PMC: 10074943.
DOI: 10.1016/j.bbadva.2023.100074.
Ribosomal incorporation of negatively charged d-α- and -methyl-l-α-amino acids enhanced by EF-Sep.
Katoh T, Suga H
Philos Trans R Soc Lond B Biol Sci. 2023; 378(1871):20220038.
PMID: 36633283
PMC: 9835608.
DOI: 10.1098/rstb.2022.0038.
Ribosome-mediated biosynthesis of pyridazinone oligomers in vitro.
Lee J, Coronado J, Cho N, Lim J, Hosford B, Seo S
Nat Commun. 2022; 13(1):6322.
PMID: 36280685
PMC: 9592601.
DOI: 10.1038/s41467-022-33701-2.
In Vitro Selection of Macrocyclic α/β-Peptides against Human EGFR.
Wakabayashi R, Kawai M, Katoh T, Suga H
J Am Chem Soc. 2022; 144(40):18504-18510.
PMID: 36173923
PMC: 9563295.
DOI: 10.1021/jacs.2c07624.